Could a 3-Day TMS course ease functional seizures?
NCT ID NCT07059325
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early study tests whether an accelerated form of transcranial magnetic stimulation (TMS) is feasible and tolerable for people with functional seizures (also called psychogenic non-epileptic seizures). Thirty adults will receive up to 30 TMS sessions over 3–5 days, targeting the left prefrontal cortex. Researchers will measure how many complete the treatment, track side effects, and monitor seizure frequency and quality of life at 4 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
transcranial magnetic stimulation (TMS)
What this could lead to
If it works, this could point toward a fast, non-drug treatment to reduce functional seizures and improve quality of life.
What could go wrong
This is a very early, small, open-label trial with no placebo group. Results may not prove effectiveness, and side effects like headache or dizziness are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNCTIONAL NEUROLOGICAL SYMPTOM DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Psychiatry, Brain Stimulation Department
RECRUITINGCharleston, South Carolina, 29425, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact